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1. Introduction 
Greater trochanteric pain syndrome (GTPS) is a degenerative condition of the gluteus medius 
(GMed) and minimus (GMin) tendons and the trochanteric/surrounding bursae that causes 
debilitating pain over the lateral aspect of the hip (Bird et al. , 2001, Oakley et al. , 1999, 
Woodley et al. , 2008). Despite limited epidemiological research, GTPS commonly affects 
post-menopausal women and the unilateral and bilateral prevalence of this condition is 
reported to be 15.0% and 8.5% respectively, in community-dwelling women between 50 and 
79 years (Del Buono et al. , 2012, Lievense et al. , 2005). Clinically, these women complain 
of pain lying on their side, ascending and descending stairs, walking, and moving from a 
sitting to standing position (Collee et al. , 1990, Gordon, 1961, Karpinski and Piggott, 1985, 
Lequesne et al. , 2008, Schapira et al. , 1986, Shbeeb et al. , 1996, Spear and Lipscomb, 1952, 
Tortolani et al. , 2002, Woodley, Nicholson, 2008). 
 
The GMed and GMin muscles are crucial for the lateral stability of the hip joint and pelvis, 
particularly in unilateral stance. Deficits in these stabilising muscles exist in GTPS (Allison et 
al. , 2016a), including GMin and GMed (Woodley, Nicholson, 2008), however the detailed 
activation of these muscles is unknown. Using ultrasound, GMin has been shown to activate 
earlier in subjects with chronic hip pain during a step down function task (Dieterich et al. , 
2016), however there is no way of investigating amplitude of activation using this method. In 
the GTPS population, there is a lack of research into gluteal muscle activation during gait, 
despite walking being a common aggravator of lateral hip pain. Identification of differences 
in hip stabilising muscle activation during gait, between GTPS and control groups, may 
facilitate targeted rehabilitation programs to address muscle impairments and dysfunction, 
and enable gait phase-specific interventions. 
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Fine wire electromyography (EMG) research suggests that anterior and posterior portions 
within GMin and anterior, middle and posterior portions within GMed have unique activation 
properties across the gait cycle (Semciw et al. , 2014, Semciw et al. , 2013c). In healthy 
young adults, posterior GMin has its greatest burst of activation early in the gait cycle, while 
anterior GMin has its greatest burst in mid to late stance (Semciw, Green, 2014). This 
functional differentiation facilitates pelvic and femoral head stability across the entire range 
of movement. It is important then to consider segmental gluteal muscle activation in GTPS 
where hip muscle function is thought to be impaired.  
 
Similarly, variability in muscle activation in this population is unknown. It has been reported 
that in other chronic conditions, variability of movement patterns and/or muscle activation is 
reduced (Edwards et al. , 2016, Heiderscheit et al. , 2002, Miller et al. , 2008, Seay et al. , 
2011, Selles et al. , 2001). Implications of this may include chronic overload of the musculo-
tendinous unit, thus associated pain and injury.  
 
The aim of this research was to investigate, quantify and compare temporal and amplitude, 
measures of muscle activation in the anterior and posterior portions of GMin and the anterior, 
middle and posterior portions of GMed and tensor fascia latae (TFL) during gait, in post-
menopausal women with and without GTPS. A secondary aim was to assess if differences in 
muscle activation variability existed between control and GTPS groups. 
 
2. Methods: 
2.1 Participants 
Eight post-menopausal women with GTPS (mean age 58.9, SD 3.3) and 10 control post-
menopausal women (mean age 60.2, SD 2.6) participated in this study. Post-menopausal 
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status was determined by >12 months of amenorrhea as per the Australasian Menopause 
Society guidelines (Australasian Menopause Society, 2008), or recorded as of the date of 
hysterectomy. Control participants had no history of congenital hip disease, hip or back 
surgery, hip trauma, or any lower limb or lumbar spine pain or injury in the last 6-months. 
Post-menopausal women with GTPS were included if they scored <80 points on the VISA-G 
questionnaire (Fearon et al. , 2015) and had lateral hip pain reproduction on 3 of 5 clinical 
tests (Trendelenburg test (Lequesne, Mathieu, 2008), palpation of the greater trochanter 
(Dennison and Beverland, 2002), Patrick-faber test (Mitchell et al. , 2003) standard and/or 
modified resisted external derotation test (Lequesne, Mathieu, 2008)). Participants who 
reported signs or symptoms consistent with intra-articular hip pathology or osteoarthritis 
(locking or catching in the joint, range of movement restriction, difficulty manipulating shoes 
and socks) were excluded (Fearon et al. , 2013). Ethical approval was granted by the La 
Trobe University Human Ethics Committee (UHEC 14-056), and all participants provided 
written informed consent. 
2.2 Instrumentation and electrode insertions 
Eligible participants attended one EMG testing session that involved the application of 
intramuscular electrodes into five muscle segments: anterior and posterior segments of the 
GMin muscle, and anterior, middle and posterior segments of GMed and one surface 
electrode onto TFL. Stainless-steel Teflon® coated bipolar fine-wire intramuscular electrodes 
were prepared with a 1mm conductive tip, and inserted under real-time ultrasound guidance 
(HDI 3000; Advanced Technology Laboratories, USA) using previously described 
procedures (Semciw et al. , 2013a, Semciw et al. , 2013b). In brief, five insertion sites were 
marked on the stance dominant leg (testing leg) of control participants and the symptomatic 
leg of GTPS participants, with reference to major surface landmarks (Semciw, Pizzari, 
2013b). Leg dominance was assessed using three previously described tests: stamp out an 
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imaginary fire, kick a ball and step up onto a block (Bullock-Saxton et al. , 2001). The skill-
dominant leg was the leg that completed at least 2/3 tasks and the contralateral leg, the stance 
limb. Where participants had GTPS bilaterally, participants were asked to select their ‘most 
symptomatic leg’. TFL surface electrode application and placement was completed using the 
recommendations of Basmajian and De Luca (1985). 
 
Footswitches (Model: 402, Interlink Electronics, USA) were positioned bilaterally on the 
plantar aspect of the heel and interphalangeal joint of the hallux, and used to record temporal 
aspects (phases) of the gait cycle (Semciw, Pizzari, 2013c).  
Raw signals from the footswitches, surface and intramuscular electrodes were received by a 
Delsys Trigno
TM
 Wireless EMG system (Delsys Inc., Boston, USA). This device samples 
EMG signals with 16 bits.  
2.3 Experimental Protocol: 
Prior to the commencement, participants were instructed to complete a three minute warm up 
to familiarise themselves with the walking trial protocol. The experimental protocol involved 
two components: walking trials to determine muscle activation patterns during gait, and 
isometric muscle strength testing to evaluate strength differences, between GTPS and control 
participants.  
 
Six walking trials were completed at a comfortable self-selected walking speed (Latt et al. , 
2008) along a 10m walkway (Semciw, Green, 2014). Trials were timed with a stop-watch and 
were repeated if the average walking speed increased or decreased by >5% (established 
during warm-up).  
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Isometric strength measures were undertaken during testing leg hip abduction in side-lie and 
hip internal/external rotation in sitting according to the methods described in Thorborg et al 
(2010), and hip ER in clam position (45° hip flexion and 90° knee flexion). All strength 
measures were completed using a hand-held dynamometer secured with a seat belt for 
standardisation (Table 2). This ensured consistent and sustained resistance to the participant 
force. Each isometric trial was performed three times for 3 s, with a 3-min respite between 
each trial to reduce fatigue effects. The standardised encouragement given by the examiner 
was ‘‘go ahead push-push-push-push and relax’’(Thorborg, Petersen, 2010).  
 
After the series of walking trials, and after each isometric strength test, participants were 
asked to rate their level of discomfort by placing a mark on a 10cm visual analogue scale 
(VAS) where 0cm = no discomfort and 10cm = maximum possible discomfort. Self-reported 
activation was assessed using the Minnesota Leisure Time Physical Activation Questionnaire 
(Taylor et al. , 1978). 
 
2.4 Data processing 
Raw signals collected by the Delsys EMGworks Acquisition software (CMRR >80 dB at 
60Hz; gain of 1000; band pass filtered 20-900 Hz) were sampled at 2000Hz. Intramuscular 
EMG signals from GMed and GMin were high pass filtered (4
th
 order Butterworth, 50Hz cut-
off) to reduce low frequency movement artefact (Semciw, Pizzari, 2013c). The surface 
electrode (TFL) was high pass filtered at 10Hz. All data were then full wave rectified and 
further processed with a low pass filter (4
th
 order Butterworth) at a cut off frequency of 6Hz 
to generate linear envelopes. Electromyographic signals for each muscle were amplitude 
normalised to the respective peak muscle activation recorded during the gait cycle (Yang and 
Winter, 1984), and time normalised to 100-points (% of the gait cycle). It has previously been 
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considered that normalising to maximum voluntary isometric contraction (MVIC) is 
inaccurate in people with pain (Sims et al. , 2002). Normalising to peak muscle activity 
within the gait cycle is an alternative normalisation method that has greater intra-subject 
reliability than MVIC methods (Suydam et al. , 2016). Data processing and analysis was 
completed by one investigator (blinded to group allocation), based on previously validated 
procedures (high intra-rater reliability: ICC2,1 0.965-1.000) (Semciw, Green, 2014). 
The first and last walking trials were excluded to reduce learning and fatigue effects. Two 
consecutive strides, representing the two middle strides of each of the four walking trials 
were processed for analysis (8 strides per participant). This ensured consistent walking 
velocity between the trials by excluding acceleration and deceleration periods. For each 
participant, an ensemble of average muscle activation across eight strides was generated. This 
was summed and averaged across all participants within each group (GTPS and control) to 
generate a grand ensemble curve across the gait cycle.  Average level of muscle activation 
across all participants was calculated to produce a grand ensemble for each muscle segment 
(anterior GMin, posterior GMin, anterior GMed, middle GMed, posterior GMed and TFL). 
Similarly, walking trial discomfort data and isometric strength measures were averaged 
across participants.  
Previous research in young healthy subjects divided analyses of gait into distinct bursts of 
activation (Rutherford and Hubley-Kozey, 2009, Semciw, Green, 2014, Semciw, Pizzari, 
2013c). Ensembles indicated two distinct bursts of activation, during early stance (0-30% gait 
cycle) and late stance (30% to toe off). Therefore data were acquired for 4 phases in total: 0-
30% and 30%-toe off, total stance (0% to toe off) and swing (toe off to end of the gait cycle).  
Delsys EMGworks 4.0 signal analysis software was used to acquire the dependant variables 
of peak amplitude (% peak muscle activation), average amplitude (% peak muscle activation) 
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and time to peak (TTP, % of gait cycle) for each muscle segment from each phase of the gait 
cycle, established from the linear envelopes of each participant’s trials. Variability of muscle 
activation was calculated using the mean coefficient of variation (CV) across the eight strides 
within each participant (Kiss et al. , 2012). These were determined using values from each 
one percent increment of the gait cycle and averaged within each phase (0-30%, 30-60%, 0-
TO and entire gait cycle). The CV for each participant within each phase was summed and 
averaged within each group (GTPS vs. control). 
Strength measures (Newtons), were multiplied by the lever arm to calculate peak torque and 
normalised to body mass (Jaric et al. , 2005). This normalisation method (Table 2) is used to 
account for differences in available muscle mass with increasing body size (Jaric, Mirkov, 
2005).  
2.5 Statistical analysis 
The temporal and amplitude gait variables from each segment in each phase were used for 
quantitative comparisons (peak amplitude, average amplitude and time to peak). Histograms 
and the Kolmogorov-Smirnov (K–S) test were used to explore assumptions of normality 
(Field, 2009). Independent samples t-tests were performed to identify differences in 
dependant variables (EMG data, peak torque, walking speed, discomfort ratings and mean 
CV) between groups. To estimate of the magnitude of difference (effect size) between 
groups, a standardised mean difference (SMD = mean difference/pooled SD) was calculated 
for all gait comparisons (Field, 2009). For non-parametric data, effect sizes were calculated 
by dividing the z-score of the Mann–Whitney U test by the square root of the total sample 
size (Field, 2009). An effect size threshold of 0.2, 0.5 and 0.8 was considered small, medium 
and large respectively(Cohen, 1988). All statistical analyses were performed in SPSS 
(version 21, IBM SPSS Inc., Chicago, IL, USA) using an alpha of 0.05. 
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3. Results 
Participant baseline characteristics is outlined in Table 1. All intramuscular electrodes except 
one posterior GMin (GTPS participant) remained in situ for the entire testing session. One 
middle GMed intramuscular electrode signal (control participant) and one TFL surface 
electrode signal (control participant) were affected by artefact and could not be processed, 
and consequently discarded from analysis. The mean (SD) walking speed for was 0.74 (0.06) 
m.s
-1
 for the control group and 0.90 (0.14) m.s
-1
 for GTPS participants (p=0.013). Mean (SD) 
stride time was 1.01 (0.07) for control participants and 1.09 (0.10)s for GTPS participants 
(p=0.057). Level of discomfort (mean (SD)) for comfortable pace walking trials for control 
and GTPS participants was 2.12(1.46) cm and 4.96(1.61) cm respectively (p=0.003). The 
GTPS group had significantly less hip muscle peak torque during abduction and clam 
strength tests (Table 3) and significantly higher discomfort scores (p=0.003). 
 
Table 4 presents quantitative comparisons of TFL and segmental gluteal amplitude and 
temporal EMG variables between control and GTPS participants, when normalised to 
percentage of peak muscle activation.  
 
The ensemble curves for posterior GMin illustrate a large first burst of activation followed by 
a small burst, in both GTPS and control participants. There was significantly greater average 
and peak posterior GMin muscle activation, with large effect sizes, in GTPS participants 
during the first phase (0-30%), <p=0.01 and p=0.04 respectively. An earlier peak in GTPS 
group muscle activation in gluteus minimus posterior was found in the second burst (30%-
TO), and also for the entire duration of stance phase.  
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The shape of the anterior GMin ensemble differs between GTPS and controls. For the GTPS 
group, the ensemble curve illustrates a larger first burst than the second, whereas the control 
group illustrates a smaller first burst compared with the second. GTPS participants had 
significantly greater average muscle activation, with large effect, in anterior GMin over the 
entirety of stance phase (0%-TO). Nil other significant differences existed between groups. 
The shape of the ensemble for all GMed segments are consistent between GTPS and control 
participants, however, the magnitude of activation differs. A large first burst was seen for 
both groups, however, a smaller second burst of activation is seen in the control group. 
During both the second burst of stance phase (30%-TO) and over entirety of stance (0%-TO), 
GTPS participants showed significantly higher average levels of anterior and middle GMed 
muscle activation, with moderate to large effects. Similarly more peak activation in the 
anterior and middle portions of GMed was seen during the second burst (30%-TO). An 
earlier peak in GTPS muscle activation in middle GMed during early stance (0-30%). 
No differences were found for the duration of stance from 0-TO however significantly greater 
peak TFL muscle activation was again found in the GTPS group compared to control 
participants during swing phase.  
 
Variability in muscle activation across the gait cycle was significantly greater in the control 
group compared to GTPS for anterior GMin and anterior GMed across stance phase, and 
more specifically 30-60% (late stance) of the gait cycle (ES>1.04, p<0.05; Table 5). 
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Table 1. Baseline Characteristics 
 
a
 non-parametric test (Mann-Whitney-U) Bold = significant result  
Control GTPS
Mean (SD) Mean (SD)
Age 60.20(2.74) 58.88(3.48) 0.379
Height 164.73(4.31) 164.89(4.55) 0.975
Weight 69.95(10.20) 87.21(53.68) 0.128
BMI 25.30(3.50) 31.38(9.50) 0.122
VISA-G Questionnaire 97.21(9.49) 55.00(6.46) <0.001a
Minnesota Activity 
Questionnaire (kcal)
p-value
0.10783.40(54.15) 42.55(37.92)
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Table 2: Method for measuring hip strength 
Action Description Lever arm and 
measurement 
Illustration 
Side-lie Hip 
Abduction 
Performed in side-lying, pillow 
between knees, with hips and 
knees in neutral, the participant 
performs a maximal isometric hip 
abduction force against the 
dynamometer positioned 5 cm 
proximal to the lateral femoral 
condyle, secured with a seat belt. 
   
Ipsilateral thigh 
segment  
 
Greater trochanter 
to the lateral 
femoral condyle 
 
 
Side-lie Clam Performed in side-lying, pillow 
between knees, with 45° hip 
flexion and 90° knee flexion, the 
participant performs a maximal 
isometric hip external rotation 
force against the dynamometer 
positioned 5 cm proximal to the 
lateral femoral condyle, secured 
with a seat belt. 
 
Ipsilateral thigh 
segment  
 
Greater trochanter 
to the lateral 
femoral condyle 
  
Seated Hip IR Participant is seated with 90° hip 
and knee flexion and holding onto 
the table with both hands. The 
participant exerts a maximum hip 
internal rotation force against the 
dynamometer applied 5 cm 
proximal to the proximal edge of 
the medial malleolus.  
 
 
 
 
 
Ipsilateral shank 
segment  
 
Fibular head to 
lateral malleolus 
 
 
Seated Hip 
ER 
Participant is seated with 90° hip 
and knee flexion and holding onto 
the table with both hands. The 
participant exerts a maximum hip 
external rotation force against the 
dynamometer applied 5 cm 
proximal to the proximal edge of 
the lateral malleolus.  
 
 
Ipsilateral shank 
segment  
 
Fibular head to 
lateral malleolus 
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  Table 3. Comparison of discomfort and peak torque measures normalised to body mass  
 
ER = external rotation; IR = internal rotation; Bold = significant result  
Peak torque adjusted for body mass (Nm/kg)
Control GTPS Control GTPS
Mean(SD) Mean(SD) Mean(SD) Mean(SD)
Hip Abd in slide-lie 0.89(1.34) 4.8(3.02) 1.67 0.00 1.07(0.07) 0.75(0.08) -4.09 0.01
Clam 1.03(1.10) 4.06(2.69) 1.49 0.01 2.44(1.39) 0.71(0.07) -1.58 0.28
Hip ER in sitting 1.26(1.57) 2.84(2.65) 0.71 0.14 0.50(0.06) 0.42(0.04) -1.46 0.33
Hip IR in sitting 1.33(1.42) 2.84(2.66) 0.70 0.14 0.62(0.05) 0.51(0.07) -1.76 0.19
Discomfort (VAS 0-10 scale)
p-value
MVIC
p-valueEffect size Effect size
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Table 4. Comparison of muscle segments across the gait cycle between control and GTPS 
groups 
 
a
 non-parametric test (Mann-Whitney-U); ~ log transformed; Bold = significant result; SD 
(standard deviation); TO (toe-off); GMin (gluteus minimus); GMed (gluteus medius) 
 
 
 
 
 
 
 
 
  
Control GTPS Control GTPS Control GTPS
Anterior GMin Stance 0-30 45.13(18.61) 58.05(12.14) 0.76 0.11 78.29(27.69) 90.52(17.06) 0.38 0.12a 16.58(6.13) 17.93(2.61) 0.26 0.57
30-TO 49.86(7.77) 51.43(13.12) 0.06 0.83a 88.70(15.37) 83.32(17.82) -0.31 0.50 11.06(5.19) 9.44(3.56) -0.34 0.46
0-TO 49.11(7.10) 55.55(4.93) 0.98 <0.05 100.00(0) 100.00(0) 0.00 1.00a 29.84(11.93) 25.45(10.76) -0.37 0.43
Swing 20.06(413.02) 17.63(11.78) -0.01 0.69 39.47(24.71) 34.21(22.83) -0.21 0.58
Posterior GMin Stance 0-30 52.24(11.42) 65.87(5.16) 0.75 <0.01
a
88.02(14.06) 100.00(0) 1.04 0.03 16.49(3.60) 13.63(2.77) -0.82 0.10
30-TO 42.40(20.15) 35.99(6.66) -0.38 0.39 72.58(33.59) 65.90(10.92) -0.24 0.59 7.95(2.48) 4.46(1.53) -1.54 <0.01
0-TO 49.14(7.34) 52.20(3.20) 0.48 0.29 100.00(0) 100.00(0) 0.00 1.00a 25.44(9.58) 13.63(2.77) -1.47 <0.01
Swing 12.64(1.12) 9.09(9.08) -0.58 0.38~ 24.10(22.80) 19.87(16.84) -0.19 0.73~
Anterior GMed Stance 0-30 58.48(5.50) 65.39(5.67) 1.18 0.02 100.00(0) 99.63(1.05) -0.26 0.70a 14.87(1.90) 15.60(2.13) 0.35 0.45
30-TO 21.88(10.34) 38.98(10.41) 1.57 <0.01 39.80(17.34) 63.90(11.86) 1.51 <0.01 9.08(3.95) 8.21(3.54) -0.25 0.63~
0-TO 43.41(4.04) 53.21(4.58) 2.18 <0.01 100.00(0) 100.00(0) 0.00 1.00b 15.19(2.10) 17.06(3.75) 0.35 0.20
Swing 10.43(7.00) 17.37(18.21) 0.50 0.34 19.70(13.59) 33.62(34.57) 0.53 0.31
Middle GMed Stance 0-30 54.37(12.49) 66.64(7.16) 0.65 <0.01
a
90.97(20.14) 99.72(0.59) 0.08 0.35~ 13.84(2.80) 13.60(2.08) -0.09 0.04~
30-TO 21.15(12.15) 35.34(7.16) 1.29 0.01 41.64(22.16) 66.93(8.75) 1.33 <0.01 7.10(4.70) 4.67(2.27) -0.59 0.29~
0-TO 41.31(8.71) 52.36(5.16) 1.40 <0.01 95.46(13.61) 100.00(0) 0.23 0.74
a
15.40(4.99) 14.34(2.64) -0.09 0.73~
Swing 20.95(24.06) 8.54(3.28) -0.63 0.53~ 38.31(39.97) 18.41(8.29) -0.60 0.89a
Posterior GMed Stance 0-30 60.13(5.30) 65.63(5.00) 1.01 <0.05 99.32(1.65) 99.94(0.15) 0.22 0.52a 13.81(2.30) 14.39(2.06) 0.25 0.59
30-TO 26.47(11.64) 32.58(7.81) 0.57 0.19 52.63(24.98) 63.32(12.70) 0.45 0.28 5.23(3.25) 4.63(2.13) -0.20 0.66
0-TO 46.12(5.54) 50.88(5.14) 0.82 0.08 100.00(0) 100.00(0) 0.00 1.00a 15.06(3.68) 14.91(3.01) 0.25 0.97~
Swing 12.54(12.09) 10.72(10.53) -0.15 0.61 22.51(118.40) 19.74(17.83) -0.03 0.75
TFL Stance 0-30 43.03(25.30) 55.87(20.10) 0.53 0.27 65.95(34.80) 75.18(25.71) 0.28 0.41 16.85(3.50) 17.65(2.91) 0.23 0.62
30-TO 48.39(14.93) 57.03(8.16) 0.67 0.17 82.96(23.33) 88.73(14.96) 0.28 0.50 15.07(3.57) 17.33(7.55) 0.37 0.54~
0-TO 48.16(13.58) 57.55(9.95) 0.74 0.13 100.00(0) 90.73(17.01) -0.41 0.20~ 32.30(14.08) 32.99(16.03) 0.23 0.93~
Swing 32.77(16.11) 45.44(11.79) 0.84 0.05~ 37.97(20.71) 80.57(14.61) 2.23 <0.01~
Muscle segment
Time to Peak (% of gait cycle) 
Mean(SD)
p-value
Phase
Average (% peak muscle activity) Peak (% peak muscle activity)
Mean(SD)
p-value
Mean(SD)
p-valueEffect size Effect size Effect size
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Table 5. Variability (mean CV) in segmental muscle activation across the gait cycle between 
control and GTPS participants 
 
Bold = significant result; SD (standard deviation); ES (effect size); GC (gait cycle); TO (toe-
off); GMin (gluteus minimus); GMed (gluteus medius) 
 
 
 
 
 
 
 
 
Mean CV SD Mean CV SD ES p-value
Total GC 0.49 0.10 0.41 0.08 0.80 0.10
0-TO 0.39 0.09 0.30 0.04 1.18 0.02
0-30 0.37 0.16 0.29 0.11 0.56 0.23
30-60 0.40 0.07 0.31 0.08 1.16 0.02
Total GC 0.49 0.15 0.43 0.05 0.49 0.26
0-TO 0.41 0.15 0.34 0.07 0.62 0.21
0-30 0.31 0.10 0.24 0.08 0.73 0.14
30-60 0.52 0.26 0.44 0.07 0.40 0.42
Total GC 0.47 0.09 0.40 0.07 0.78 0.10
0-TO 0.41 0.09 0.31 0.06 1.24 0.01
0-30 0.27 0.10 0.22 0.07 0.60 0.20
30-60 0.56 0.16 0.40 0.12 1.04 0.03
Total GC 0.48 0.14 0.39 0.07 0.70 0.14
0-TO 0.47 0.16 0.35 0.09 0.83 0.07
0-30 0.37 0.20 0.22 0.09 0.93 0.06
30-60 0.57 0.18 0.50 0.13 0.43 0.35
Total GC 0.43 0.06 0.44 0.10 0.18 0.70
0-TO 0.41 0.07 0.38 0.13 0.28 0.54
0-30 0.30 0.10 0.30 0.13 0.00 1.00
30-60 0.53 0.14 0.47 0.16 0.38 0.41
Total GC 0.35 0.13 0.30 0.09 0.41 0.39
0-TO 0.32 0.11 0.27 0.12 0.41 0.39
0-30 0.30 0.12 0.26 0.11 0.30 0.53
30-60 0.35 0.14 0.28 0.14 0.45 0.35
TFL
Anterior GMin
Muscle Phase
Control
Posterior GMin
Anterior GMed
Middle GMed
Posterior GMed
GTPS
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 [INSERT FIGURE 1] 
Discussion 
This study identified four key findings. Greater average muscle activation in all muscle 
segments was found in people with GTPS, compared to controls, however, the area that these 
segmental differences occurred varied across the gait cycle and were only significantly higher 
for anterior GMin and anterior and middle GMed during 0-TO, and posterior GMin and 
GMed during 0-30%. The EMG burst pattern of anterior GMin in participants with GTPS 
was reversed with a more dominant first burst early in stance when compared to control 
participants. Similarly, muscle activation in anterior GMin and anterior GMed was less 
variable in GTPS participants and they were significantly weaker than the control group 
during hip abduction.  
 
Reduced hip abductor strength has previously been implicated in biomechanical differences 
present in people with GTPS (Allison, Vicenzino, 2016a, Grimaldi, 2011). The loss of the 
lateral stability mechanism (frontal plane femoropelvic alignment and medio-lateral stability 
in standing) in GTPS has been attributed to hip abductor weakness (Grimaldi, 2011) which 
may cause compression of the gluteal tendons over the greater trochanter of the femur, and 
result in lateral hip pain. Pain induced inhibition of activation may also negatively effect 
strength output, as there were significant between group differences in baseline VISA-G 
scores and a significant increase in discomfort scores in the GTPS group during strength 
testing.  
 
In the GTPS group, greater average muscle activation in all muscle segments was found. The 
higher EMG amplitude may represent the need for greater motor unit recruitment given a 
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submaximal functional task, when compared to the control group (Ling et al. , 2007). The 
reduction in muscle strength may drive the need for increased neuromotor effort. This 
compensatory response to muscle weakness has been previously been demonstrated in a hip 
osteoarthritis population during gait (Dwyer et al. , 2013). On a cortical level, higher amounts 
of local gluteal and TFL muscle activation in response to unilateral loading in the GTPS 
group may demonstrate an inability to modulate corticospinal pathway excitability and 
grading of muscle activation in response to task demands. Although, all may be plausible, 
based on experimental data, a causal link cannot be claimed. 
 
A reverse of the anterior GMin EMG burst pattern was found in participants with GTPS, 
when compared to control participants. The ensembles indicate a larger burst of GTPS 
anterior GMin activation in early stance (0-30%) and although not significant, the difference 
in average amplitude in the first burst is moderate to large (ES=0.76). Control group muscle 
activation patterns reflect that which occurs in the young healthy population (Semciw, Green, 
2014) whereby anterior GMin EMG activation uniquely peaks in mid-to late stance (Semciw, 
Green, 2014). The larger second burst of activation for anterior GMin is thought to serve a 
synergistic role with iliopsoas, assisting with minimising anterior hip joint forces during mid 
to late stance (Lewis et al. , 2007) and stabilising the head of femur in the acetabulum.  In 
normal healthy gait, terminal hip extension may act as a stimulus for increased anterior GMin 
muscle activation, as it acts to stabilise the anterior aspect of the hip joint and counteract the 
hip extension moment (Semciw, Green, 2014).  Recent evidence suggests that women with 
GTPS have significantly reduced step length compared to controls (Allison et al. , 2016b), 
perhaps an adaptive strategy to relieve pain. An associated lack of terminal hip extension at 
toe off may play a role in altered muscle activation strategies during gait, through a reduced 
stimulus for anterior GMin to contract, resulting in a less dominant second burst of activation. 
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The reduced variability in the muscle recruitment in GTPS might result in an inability to 
adapt to dynamic environments (Hamill et al. , 1999) and change muscle recruitment in 
response to task demands (Stergiou et al. , 2006), and thus, may induce pathology. As the 
anterior portion of GMin and GMed are reported to be thinner than their posterior 
counterparts (Flack et al. , 2014) it is plausible that a lack of variability of movement may 
contribute to the pathology in this region.  Decreased variability has been reported in several 
other musculoskeletal conditions (Edwards, Steele, 2016, Heiderscheit, Hamill, 2002, Miller, 
Meardon, 2008, Seay, Van Emmerik, 2011, Selles, Wagenaar, 2001) and is theorised to be a 
chronic motor adaptation to pain (Hodges & Tucker 2011).  Low movement variability may 
be implicated in the recalcitrant nature of GTPS and may reflect central motor changes. 
 
Differences in muscle activation, variability and strength measures identified between groups 
may help to guide the clinical management and further research of GTPS. The prescription of 
high load isometric exercises (Rio et al. , 2015) may assist in strengthening muscle tendon 
units and support function of the lateral stability mechanism, and further investigation of gait 
kinematics may help to identify potential gait retraining strategies for normalising anterior 
hip muscle activation, stability and variability. 
 
Limitations 
The small sample size may be a limitation in this study. To achieve the same large effect size 
for anterior GMin average activation during the first burst (ES=0.76) a post-hoc sample size 
calculation indicates a sample of 29 in each group (GTPS and control) is required to reach 
statistical significance  (α=0.05 and a power of 0.80) (Faul et al. , 2007). There are inherent 
limitations for the use of surface electrode recordings, especially when recording from 
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participants with a high BMI; this may account for some of the differences found between 
groups in TFL. As intramuscular EMG research in this age group and pathological group 
have not been researched previously, results may act as pilot data for further research in this 
area. As no biomechanical analysis was undertaken, the biomechanical factors that may be 
influencing muscle activation levels during gait can only be hypothesised. Matching legs 
between control and GTPS legs may have been more preferable, as we cannot assume that the 
stance leg or skill leg becomes symptomatic. An estimate of proximal femoral torsion in 
participants was not recorded. This may influence GMed EMG amplitude (Nyland et al. , 
2004) and may confound the measurements. As the study was undertaken in post-menopausal 
older women (controls and GTPS), generalisability to other populations is limited.  
   
Conclusion 
Increased segmental gluteal muscle activation, decreased hip abduction strength, and reduced 
variability in muscle activation was found in post-menopausal women with GTPS, compared 
with controls – a combination that may lead to higher gluteal tendon load and result in pain. 
The inverse pattern in average anterior GMin muscle activation in the GTPS group may be 
inherently linked to altered gait characteristics. The larger burst of muscle activation seen in 
early gait during unilateral loading could influence the functioning of this segment as an 
anterior hip joint stabiliser in terminal extension.  Further work needs to explore the 
mechanism of these changes, investigate targeted gait and rehabilitation strategies, and 
identify methods for increasing strength, reducing pain and normalising variability of muscle 
activation in GTPS. 
 
Conflict of interest 
Nil declared 
  
20 
 
 
Acknowledgements 
CG acknowledges the Australian Postgraduate Award scheme and the Graduate Assistantship 
program at La Trobe University for her PhD scholarship funding. All authors acknowledge 
receipt of $400 of funding from La Trobe University for the purchase of disposable 
electromyography equipment. Funding bodies were not involved in the design, collection, 
analysis, and interpretation of data; in the writing of the manuscript; or in the decision to 
submit the manuscript for publication. JC acknowledges an affiliation with the Australian 
Centre for Research into Sports injury and its Prevention, which is one of the international 
research centres for Prevention of Injury and Protection of Athlete Health supported by the 
International Olympic Committee (IOC).  
  
  
21 
 
References 
 
Allison K, Vicenzino B, Wrigley TV, Grimaldi A, Hodges PW, Bennell KL. Hip Abductor 
Muscle Weakness in Individuals with Gluteal Tendinopathy. Medicine and Science in Sports 
and Exercise. 2016a;48:346-52. 
Allison K, Wrigley TV, Vicenzino B, Bennell KL, Grimaldi A, Hodges PW. Kinematics and 
kinetics during walking in individuals with gluteal tendinopathy. Clinical Biomechanics. 
2016b. 
Australasian Menopause Society. Diagnosing menopause. Australia: Australasian Menopause 
Society Limited 2008. 
Basmajian JV, De Luca CJ. Muscles alive: their functions revealed by electromyography. 5th 
ed. Baltimore: Williams & Wilkins; 1985. 
Bird PA, Oakley SP, Shnier R, Kirkham BW. Prospective evaluation of magnetic resonance 
imaging and physical examination findings in patients with greater trochanteric pain 
syndrome. Arthritis Rheumatology. 2001;44:2138-45. 
Bullock-Saxton JE, Wong WJ, Hogan N. The influence of age on weight-bearing joint 
reposition sense of the knee. Experimental brain research. 2001;136:400-6. 
Cohen J. Statistical power analysis for the behavioral sciences. Hillsdale: Lawrence Erlbaum; 
1988. 
Collee G, Dijkmans BA, Vandenbroucke JP, Rozing PM, Cats A. A clinical epidemiological 
study in low back pain. Description of two clinical syndromes. British Journal of 
Rheumatology. 1990;29:354-7. 
Del Buono A, Papalia R, Khanduja V, Denaro V, Maffulli N. Management of the greater 
trochanteric pain syndrome: a systematic review. British Medical Bulletin. 2012;102:115-31. 
  
22 
 
Dennison J, Beverland DE. An audit of trochanteric bursitis in total hip arthroplasty and 
recommendations for treatment. Orthopaedic Nursing. 2002;6:5-8. 
Dieterich AV, Deshon L, Strauss GR, McKay J, Pickard CM. M-Mode Ultrasound Reveals 
Earlier Gluteus Minimus Activity in Individuals With Chronic Hip Pain During a Step-down 
Task. Journal of Orthopaedic and Sports Physical Therapy. 2016;46:277-85. 
Dwyer MK, Stafford K, Mattacola CG, Uhl TL, Giordani M. Comparison of gluteus medius 
muscle activity during functional tasks in individuals with and without osteoarthritis of the 
hip joint. Clinical Biomechanics. 2013;28:757-61. 
Edwards S, Steele JR, McGhee DE, Purdam CR, Cook JL. Asymptomatic players with a 
patellar tendon abnormality do not adapt their landing mechanics when fatigued. Journal of 
Sports Sciences. 2016:1-8. 
Faul F, Erdfelder E, Lang AG, Buchner A. G*Power 3: a flexible statistical power analysis 
program for the social, behavioral, and biomedical sciences. Behavior Research Methods. 
2007;39:175-91. 
Fearon AM, Ganderton C, Scarvell JM, Smith PN, Neeman T, Nash C, et al. Development 
and validation of a VISA tendinopathy questionnaire for greater trochanteric pain syndrome, 
the VISA-G. Manual Therapy. 2015;20:805-13. 
Fearon AM, Scarvell JM, Neeman T, Cook JL, Cormick W, Smith PN. Greater trochanteric 
pain syndrome: defining the clinical syndrome. British Journal of Sports Medicine. 
2013;47:649-53. 
Field A. Discovering statistics using IBM SPSS Statistics. London: SAGE publications Ltd; 
2009. 
Flack NA, Nicholson HD, Woodley SJ. The anatomy of the hip abductor muscles. Clinical 
Anatomy. 2014;27:241-53. 
  
23 
 
Gordon E. Trochanteric bursitis and tendinitis. Clinical Orthopaedics and Related Research. 
1961;20:193-202. 
Grimaldi A. Assessing lateral stability of the hip and pelvis. Man Ther. 2011;16:26-32. 
Hamill J, van Emmerik RE, Heiderscheit BC, Li L. A dynamical systems approach to lower 
extremity running injuries. Clinical Biomechanics. 1999;14:297–308. 
Heiderscheit BC, Hamill J, Van Emmerik REA. Variability of stride characteristics and joint 
coordination among individuals with unilateral patellofemoral pain. Journals of Applied 
Biomechanics. 2002;18:110-21. 
Jaric S, Mirkov D, Markovic G. Normalising physical performance tests for body size: a 
proposal for standardisation. Journal of Strength & Conditioning Research (Allen Press 
Publishing Services Inc). 2005;19:467-74. 
Karpinski MR, Piggott H. Greater trochanteric pain syndrome. A report of 15 cases. Journal 
of Bone & Joint Surgery - British Volume. 1985;67:762-3. 
Kiss RM, Bejek Z, Szendroi M. Variability of gait parameters in patients with total knee 
arthroplasty. Knee surgery, Sports traumatology, Arthroscopy. 2012;20:1252-60. 
Latt MD, Menz HB, Fung VS, Lord SR. Walking speed, cadence and step length are selected 
to optimize the stability of head and pelvis accelerations. Experimental Brain Research. 
2008;184:201-9. 
Lequesne M, Mathieu P, Vuillemin-Bodaghi V, Bard H, Djian P. Gluteal tendinopathy in 
refractory greater trochanter pain syndrome: diagnostic value of two clinical tests. Arthritis 
and Rheumatology. 2008;59:241-6. 
Lewis CL, Sahrmann SA, Moran DW. Anterior hip joint force increases with hip extension, 
decreased gluteal force, or decreased iliopsoas force. Journal of Biomechanics. 
2007;40:3725-31. 
  
24 
 
Lievense A, Bierma-Zeinstra S, Schouten B, Bohnen A, Verhaar J, Koes B. Prognosis of 
trochanteric pain in primary care. British Journal of General Practice. 2005;55:199-204. 
Ling SM, Conwit RA, Talbot L, Shermack M, Wood JE, Dredge EM, et al. 
Electromyographic patterns suggest changes in motor unit physiology associated with early 
osteoarthritis of the knee. Osteoarthritis Cartilage. 2007;15:1134-40. 
Miller RH, Meardon SA, Derrick TR, Gillette JC. Continuous relative phase variability 
during an exhaustive run in runners with a history of iliotibial band syndrome. Journal of 
Applied Biomechanics. 2008;24:262-70. 
Mitchell B, McCrory P, Brukner P, O'Donnell J, Colson E, Howells R. Hip Joint Pathology: 
Clinical Presentation and Correlation Between Magnetic Resonance Arthrography, 
Ultrasound, and Arthroscopic Findings in 25 Consecutive Cases. Clinical Journal of Sport 
Medicine. 2003;13:152-6. 
Nyland J, Kuzemchek S, Parks M, Caborn DN. Femoral anteversion influences vastus 
medialis and gluteus medius EMG amplitude: composite hip abductor EMG amplitude ratios 
during isometric combined hip abduction-external rotation. Journal of Electromyography & 
Kinesiology. 2004;14:255-61. 
Oakley SP, Bird P, Kirkham BW. Gluteus medius (GM) tears presenting as the clinical 
syndrome of trochanteric bursitis. Arthritis and rheumatism. 1999;42:S340-S. 
Rio E, Kidgell D, Purdam C, Gaida J, Moseley GL, Pearce AJ, et al. Isometric exercise 
induces analgesia and reduces inhibition in patellar tendinopathy. British Journal of Sports 
Medicine. 2015. 
Rutherford DJ, Hubley-Kozey C. Explaining the hip adduction moment variability during 
gait: Implications for hip abductor strengthening. Clinical Biomechanics. 2009;24:267-73. 
Schapira D, Nahir M, Scharf Y. Trochanteric bursitis: a common clinical problem. Archives 
of Physical Medicine and Rehabilitation. 1986;67:815-7. 
  
25 
 
Seay JF, Van Emmerik REA, Hamill J. Low back pain status affects pelvis-trunk 
coordination and variability during walking and running. Clinical Biomechanics,. 
2011;26:572–8. 
Selles RW, Wagenaar RC, Smit TH, Wuisman PI. Disorders in trunk rotation during walking 
in patients with low back pain: a dynamical systems approach. Clinical Biomechanics. 
2001;16:175–81. 
Semciw AI, Green RA, Murley GS, Pizzari T. Gluteus minimus: an intramuscular EMG 
investigation of anterior and posterior segments during gait. Gait & Posture. 2014;39:822-6. 
Semciw AI, Green RA, Pizzari T, Briggs C. Verification of a standardized method for 
inserting intramuscular EMG electrodes into uniquely oriented segments of gluteus minimus 
and gluteus medius. Clinical Anatomy. 2013a;26:244-52. 
Semciw AI, Pizzari T, Green RA. Technical application and the level of discomfort 
associated with an intramuscular electromyographic investigation into gluteus minimus and 
gluteus medius. Gait and Posture. 2013b;38:157-60. 
Semciw AI, Pizzari T, Murley GS, Green RA. Gluteus medius: an intramuscular EMG 
investigation of anterior, middle and posterior segments during gait. Journal of 
electromyography and kinesiology : official journal of the International Society of 
Electrophysiological Kinesiology. 2013c;23:858-64. 
Shbeeb MI, O'Duffy JD, Michet CJ, Jr., O'Fallon WM, Matteson EL. Evaluation of 
glucocorticosteroid injection for the treatment of trochanteric bursitis. Journal of 
Rheumatology. 1996;23:2104-6. 
Sims KJ, Richardson CA, Brauer SG. Investigation of hip abductor activation in subjects with 
clinical unilateral hip osteoarthritis. Annals of the Rheumatic Diseases. 2002;61:687-92. 
Spear IM, Lipscomb PR. Noninfectious trochanteric bursitis and peritendinitis. Surgical 
Clinics of North America. 1952:1217-24. 
  
26 
 
Stergiou N, Harbourne RT, Cavanaugh JT. Optimal movement variability: A new theoretical 
perspective for neurologic physical therapy. Journal of Neurologic Physical Therapy. 
2006;30:120-9. 
Suydam SM, Manal K, Buchanan TS. The Advantages of Normalizing EMG to Ballistic 
Rather Than Isometric or Isokinetic Tasks. Journal of Applied Biomechanics. 2016:1-26. 
Taylor HL, Jacobs JDR, Schucker B, Knudsen J, Leon AS, Debacker G. A questionnaire for 
the assessment of leisure time physical activities. Journal of Chronic Diseases. 1978;31:741-
55. 
Thorborg K, Petersen J, Magnusson SP, Hölmich P. Clinical assessment of hip strength using 
a hand-held dynamometer is reliable: Clinical assessment of hip strength. Scandinavian 
Journal of Medicine & Science in Sport. 2010;20:493-501. 
Tortolani PJ, Carbone JJ, Quartararo LG. Greater trochanteric pain syndrome in patients 
referred to orthopedic spine specialists. The Spine Journal. 2002;2:251-4. 
Woodley SJ, Nicholson HD, Livingstone V, Doyle TC, Meikle GR, Macintosh JE, et al. 
Lateral hip pain: findings from magnetic resonance imaging and clinical examination. Journal 
of Orthopaedic and Sports Physical Therapy. 2008;38:313-28. 
Yang JF, Winter DA. Electromyographic amplitude normalization methods: improving their 
sensitivity as diagnostic tools in gait analysis. Archives of Physical Medicine and 
Rehabilitation. 1984;65:517-21. 
 
  
  
27 
 
Figure 1: A comparison of GTPS and control muscle activity (normalised to a % of peak muscle 
activity) during the gait cycle 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Grand ensemble EMG averages (GTPS participants = black solid lines; control participants = 
black dashed lines) for gluteus minimus anterior (anterior GMin) (10 control; 8 GTPS 
participants), gluteus minimus posterior (posterior GMin) (10 control; 7 GTPS participants), 
gluteus medius anterior (anterior GMed) (10 control; 8 GTPS participants), gluteus medius 
middle (middle GMed) (9 control; 8 GTPS participants), gluteus medius posterior (posterior 
GMed) (10 control; 8 GTPS participants) and TFL (9 control; 8 GTPS participants) across the 
gait cycle. Note, peak bursts in this figure represent mean peak activity within and across 
participants, therefore do not reflect absolute peak values of each burst in Table 3. 
  
Table 1. Baseline Characteristics 
  
Control GTPS 
p-value 
Mean (SD) Mean (SD) 
Age 60.20(2.74) 58.88(3.48) 0.379 
Height 164.73(4.31) 164.89(4.55) 0.975 
Weight 69.95(10.20) 87.21(53.68) 0.128 
BMI 25.30(3.50) 31.38(9.50) 0.122 
VISA-G Questionnaire 97.21(9.49) 55.00(6.46) <0.001a 
Minnesota Activity  
83.40(54.15) 42.55(37.92) 0.107 
Questionnaire (kcal) 
a
 non-parametric test (Mann-Whitney-U) Bold = significant result 
  
 
 Table 3. Comparison of discomfort and peak torque measures normalised to body mass 
MVIC 
Discomfort (VAS 0-10 scale) Peak torque adjusted for body mass (Nm/kg) 
Control GTPS 
Effect size p-value 
Control GTPS 
Effect size 
p-
value Mean(SD) Mean(SD) Mean(SD) Mean(SD) 
Hip Abd in slide-
lie 0.89(1.34) 4.8(3.02) 1.67 0.00 1.07(0.07) 0.75(0.08) -4.09 0.01 
Clam 1.03(1.10) 4.06(2.69) 1.49 0.01 2.44(1.39) 0.71(0.07) -1.58 0.28 
Hip ER in sitting 1.26(1.57) 2.84(2.65) 0.71 0.14 0.50(0.06) 0.42(0.04) -1.46 0.33 
Hip IR in sitting 1.33(1.42) 2.84(2.66) 0.70 0.14 0.62(0.05) 0.51(0.07) -1.76 0.19 
ER = external rotation; IR = internal rotation; Bold = significant result 
 
 
 
  
Table 5. Variability (mean CV) in segmental muscle activation across the gait cycle between control and GTPS participants 
Muscle Phase 
Control GTPS     
Mean CV SD Mean CV SD ES p-value 
Anterior GMin Total GC 0.49 0.10 0.41 0.08 0.80 0.10 
0-TO 0.39 0.09 0.30 0.04 1.18 0.02 
0-30 0.37 0.16 0.29 0.11 0.56 0.23 
30-60 0.40 0.07 0.31 0.08 1.16 0.02 
Posterior GMin Total GC 0.49 0.15 0.43 0.05 0.49 0.26 
0-TO 0.41 0.15 0.34 0.07 0.62 0.21 
0-30 0.31 0.10 0.24 0.08 0.73 0.14 
30-60 0.52 0.26 0.44 0.07 0.40 0.42 
Anterior GMed Total GC 0.47 0.09 0.40 0.07 0.78 0.10 
0-TO 0.41 0.09 0.31 0.06 1.24 0.01 
0-30 0.27 0.10 0.22 0.07 0.60 0.20 
30-60 0.56 0.16 0.40 0.12 1.04 0.03 
Middle GMed Total GC 0.48 0.14 0.39 0.07 0.70 0.14 
0-TO 0.47 0.16 0.35 0.09 0.83 0.07 
0-30 0.37 0.20 0.22 0.09 0.93 0.06 
30-60 0.57 0.18 0.50 0.13 0.43 0.35 
Posterior GMed Total GC 0.43 0.06 0.44 0.10 0.18 0.70 
0-TO 0.41 0.07 0.38 0.13 0.28 0.54 
0-30 0.30 0.10 0.30 0.13 0.00 1.00 
30-60 0.53 0.14 0.47 0.16 0.38 0.41 
TFL Total GC 0.35 0.13 0.30 0.09 0.41 0.39 
0-TO 0.32 0.11 0.27 0.12 0.41 0.39 
0-30 0.30 0.12 0.26 0.11 0.30 0.53 
30-60 0.35 0.14 0.28 0.14 0.45 0.35 
 
Bold = significant result; SD (standard deviation); ES (effect size); GC (gait cycle); TO (toe-off); GMin (gluteus minimus); GMed (gluteus medius) 
 
  
 
 
Muscle segment Phase 
Average (% peak muscle activity) Peak (% peak muscle activity) Time to Peak (% of gait cycle)  
Mean(SD) 
Effect size p-value 
Mean(SD) 
Effect size p-value 
Mean(SD) 
Effect size p-value 
Control GTPS Control GTPS Control GTPS 
Anterior GMin Stance 0-30 45.13(18.61) 58.05(12.14) 0.76 0.11 78.29(27.69) 90.52(17.06) 0.38 0.12a 16.58(6.13) 17.93(2.61) 0.26 0.57 
  
30-TO 49.86(7.77) 51.43(13.12) 0.06 0.83a 88.70(15.37) 83.32(17.82) -0.31 0.50 11.06(5.19) 9.44(3.56) -0.34 0.46 
  
0-TO 49.11(7.10) 55.55(4.93) 0.98 <0.05 100.00(0) 100.00(0) 0.00 1.00
a
 29.84(11.93) 25.45(10.76) -0.37 0.43 
 
Swing 
 
20.06(413.02) 17.63(11.78) -0.01 0.69 39.47(24.71) 34.21(22.83) -0.21 0.58 
    
Posterior GMin Stance 0-30 52.24(11.42) 65.87(5.16) 0.75 <0.01a 88.02(14.06) 100.00(0) 1.04 0.03 16.49(3.60) 13.63(2.77) -0.82 0.10 
  
30-TO 42.40(20.15) 35.99(6.66) -0.38 0.39 72.58(33.59) 65.90(10.92) -0.24 0.59 7.95(2.48) 4.46(1.53) -1.54 <0.01 
  
0-TO 49.14(7.34) 52.20(3.20) 0.48 0.29 100.00(0) 100.00(0) 0.00 1.00a 25.44(9.58) 13.63(2.77) -1.47 <0.01 
 
Swing 
 
12.64(1.12) 9.09(9.08) -0.58 0.38~ 24.10(22.80) 19.87(16.84) -0.19 0.73~ 
    
Anterior GMed Stance 0-30 58.48(5.50) 65.39(5.67) 1.18 0.02 100.00(0) 99.63(1.05) -0.26 0.70a 14.87(1.90) 15.60(2.13) 0.35 0.45 
  
30-TO 21.88(10.34) 38.98(10.41) 1.57 <0.01 39.80(17.34) 63.90(11.86) 1.51 <0.01 9.08(3.95) 8.21(3.54) -0.25 0.63~ 
  
0-TO 43.41(4.04) 53.21(4.58) 2.18 <0.01 100.00(0) 100.00(0) 0.00 1.00b 15.19(2.10) 17.06(3.75) 0.35 0.20 
 
Swing 
 
10.43(7.00) 17.37(18.21) 0.50 0.34 19.70(13.59) 33.62(34.57) 0.53 0.31 
    
Middle GMed Stance 0-30 54.37(12.49) 66.64(7.16) 0.65 <0.01a 90.97(20.14) 99.72(0.59) 0.08 0.35~ 13.84(2.80) 13.60(2.08)  -0.09 0.04~ 
  
30-TO 21.15(12.15) 35.34(7.16) 1.29 0.01 41.64(22.16) 66.93(8.75) 1.33 <0.01 7.10(4.70) 4.67(2.27) -0.59 0.29~ 
  
0-TO 41.31(8.71) 52.36(5.16) 1.40 <0.01 95.46(13.61) 100.00(0) 0.23 0.74a 15.40(4.99) 14.34(2.64) -0.09 0.73~ 
 
Swing 
 
20.95(24.06) 8.54(3.28) -0.63 0.53~ 38.31(39.97) 18.41(8.29) -0.60 0.89a 
    
Posterior GMed Stance 0-30 60.13(5.30) 65.63(5.00) 1.01 <0.05 99.32(1.65) 99.94(0.15) 0.22 0.52a 13.81(2.30) 14.39(2.06) 0.25 0.59 
  
30-TO 26.47(11.64) 32.58(7.81) 0.57 0.19 52.63(24.98) 63.32(12.70) 0.45 0.28 5.23(3.25) 4.63(2.13) -0.20 0.66 
  
0-TO 46.12(5.54) 50.88(5.14) 0.82 0.08 100.00(0) 100.00(0) 0.00 1.00a 15.06(3.68) 14.91(3.01) 0.25 0.97~ 
 
Swing 
 
12.54(12.09) 10.72(10.53) -0.15 0.61 22.51(118.40) 19.74(17.83) -0.03 0.75 
    
TFL Stance 0-30 43.03(25.30) 55.87(20.10) 0.53 0.27 65.95(34.80) 75.18(25.71) 0.28 0.41 16.85(3.50) 17.65(2.91) 0.23 0.62 
  
30-TO 48.39(14.93) 57.03(8.16) 0.67 0.17 82.96(23.33) 88.73(14.96) 0.28 0.50 15.07(3.57) 17.33(7.55) 0.37 0.54~ 
  
0-TO 48.16(13.58) 57.55(9.95) 0.74 0.13 100.00(0) 90.73(17.01) -0.41 0.20~ 32.30(14.08) 32.99(16.03) 0.23 0.93~ 
  Swing   32.77(16.11) 45.44(11.79) 0.84 0.05~ 37.97(20.71) 80.57(14.61) 2.23 <0.01~         
Table 4. Comparison of muscle segments across the gait cycle between control and GTPS groups 
 
a
 non-parametric test (Mann-Whitney-U); ~ log transformed; Bold = significant result; SD (standard deviation); TO (toe-off); GMin (gluteus minimus); 
GMed (gluteus medius) 
groups 
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